Arkema, FR0010313833

Arkema stock gains after Bernstein lifts its target to 67 euros

Published on 08/21/2026 at 22:17 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Arkema stock is getting support from a Bernstein target increase to 67 euros, while the shares trade at 60.05 euros and the stock is up 10.78% this year.

Schwarzweiß-Dokumentarfoto von zwei Arbeitern mit Helmen an Rohrleitungen in Chemieanlage
Schwarzweiß-Reportagebild zeigt Arbeiter in Schutzausrüstung, steht sinnbildlich für Arkema S.A. FR0010313833 und industrielle Chemieproduktion, Illustration mit AI erstellt.

Arkema (FR0010313833) stock is trading at 60.05 euros as of August 21, 2026, after a Bernstein move lifted the company's target to 67 euros from 61 euros and the shares showed a 1st Jan change of +10.78% on MarketScreener's real-time CBOE feed. The same snapshot shows a 5-day change of +1.65%, which keeps the recent tone constructive without relying on a larger narrative.

Target hike frames the move

The recommendation update was reported on August 21, 2026, and it gives the day's catalyst a precise anchor: Bernstein raised its price target to 67 euros from 61 euros for Arkema AKE.PA. That 6 euro increase is a 9.84% lift versus the prior target, a concrete comparison that matters more than broad sector language.

MarketScreener's company page also shows a market cap of 4,469 and lists a real-time quote of 60.05 euros, putting the shares 10.78% higher for 2026 while still 10.34% below the new 67 euro target. The gap between the market quote and the revised target is one of the cleanest figures on the board today.

Half-year numbers stay central

Arkema's latest reported results are the half year ended June 30, 2026, which MarketScreener flags alongside the company's own Q2 and half-year coverage. The same result set also references Q1 EBITDA of EUR 282.7 million and a full-year 2025 EBITDA figure of EUR 1.25 billion, giving investors a useful sequence from quarter to quarter and into the prior fiscal year.

One comparison stands out: Q1 EBITDA of EUR 282.7 million later fed into the half-year picture, while the full-year 2025 EBITDA of EUR 1.25 billion remains a historical reference against which the 2026 run rate can be judged. The half-year result and the 2025 baseline are the two most useful operating markers in the current flow.

What matters for Arkema

Arkema's own product set still matters because the company is exposed to specialty chemicals, and its North American PVDF expansion was completed in June 2026. That link between portfolio and capacity helps explain why analysts keep revisiting earnings power and target assumptions around the stock.

For a representative product line, Arkema's PVDF business remains one of the clearest examples of how the group ties specialty materials to battery, electronics and industrial demand. The segment is also useful for watching whether capacity additions translate into better margin discipline.

Price and position

Arkema stock trades at 60.05 euros as of August 21, 2026, with a 2026 change of +10.78% and a 5-day move of +1.65%. That leaves the shares below the updated 67 euro target, but the latest reset gives the stock a fresh reference point for near-term trading.

More on Arkema stock

Company: Arkema S.A.

ISIN: FR0010313833

Ticker: AKE.PA

Exchange: Euronext Paris

Sector / Industry: Specialty Chemicals

Index membership: CAC 40

Price (as of August 21, 2026, 5:25 a.m. ET): EUR 60.05

Market cap: EUR 4,469 million

Next earnings date: September 12, 2026

Disclaimer...

en | FR0010313833 | ARKEMA | boerse | 69983514 | bgmi